Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
CCB | C6T | Nov 22, 2024 | 0.74 | +0.04 |
CCC Intelligent Solutions | 0B1 | Nov 22, 2024 | 11.90 | +1.71 |
CCC S.A. | 6RK | Nov 22, 2024 | 48.08 | +3.53 |
CCIAM FUTURE ENERGY LTD. | 6RQ1 | Nov 22, 2024 | 0.01 | 0.00 |
CCID Consulting Co | CCX | Nov 22, 2024 | 0.09 | -28.85 |
CCL Industries Inc. | 1C9 | Nov 22, 2024 | 52.50 | 0.00 |
CCS Abwicklungs AG | C0M | Nov 22, 2024 | 0.12 | 0.00 |
CD Projekt S.A. | 7CD | Nov 22, 2024 | 36.62 | +0.27 |
CD Projekt S.A. American Depositary Receipts - Unsponsored ( | 7CD0 | Nov 22, 2024 | 9.00 | +1.12 |
CDAX (Performanceindex) | CDAX | Nov 22, 2024 | 1 663.66 | +1.02 |
CDN Maverick Capital Corp | 338B | Nov 22, 2024 | 0.09 | -1.55 |
CDW Corporation | CDW | Nov 22, 2024 | 170.75 | +1.25 |
CECO Environmental Corp. | WCE | Nov 22, 2024 | 28.60 | +0.35 |
Ceconomy AG American Depositary Receipts - Unsponsored | MEOD | Nov 22, 2024 | 0.55 | 0.00 |
Ceconomy AG. | CEC | Nov 22, 2024 | 2.96 | +0.14 |
Cedergrenska | 41C | Nov 22, 2024 | 2.28 | +3.64 |
Cegedim | C7E | Nov 22, 2024 | 10.75 | -2.27 |
Cel-Sci Corp. | LSRM | Nov 22, 2024 | 0.56 | -1.75 |
Celanese Corp | DG3 | Nov 22, 2024 | 72.16 | +4.82 |
Celestica, Inc. | CTW0 | Nov 22, 2024 | 85.50 | -1.72 |
CELL IMPACT AB | ICLA | Nov 22, 2024 | 0.02 | +45.19 |
CellaVision | C26 | Nov 22, 2024 | 18.28 | +1.67 |
Cellcom Israel Limited | F5U | Nov 22, 2024 | 4.72 | +3.51 |
Celldex Therapeutics, Inc. | TCE2 | Nov 22, 2024 | 24.80 | 0.00 |
Cellectar Biosciences | NV4 | Nov 22, 2024 | 1.47 | +6.52 |
Cellectis | ZVA | Nov 22, 2024 | 1.73 | +0.70 |
Cellectis S.A. - American Depositary Shares | ZVAA | Nov 22, 2024 | 1.72 | +0.58 |
CELLINK B | 49Z | Nov 22, 2024 | 3.07 | -1.66 |
Cellnex Telecom S.A. | 472 | Nov 22, 2024 | 32.41 | +2.56 |
Cellnex Telecom SA Unsponsored ADR (Spain) | 4720 | Nov 22, 2024 | 15.30 | +2.00 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.